Identification of cross-stage, cross-species malaria CD8⁺ T cell antigens

World Health Organization. World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance (WHO, 2025).

Leong, Y. W., Russell, B., Malleret, B. & Renia, L. Erythrocyte tropism of malarial parasites: the reticulocyte appeal. Front. Microbiol. 13, 1022828 (2022).

Junqueira, C. et al. Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes. Nat. Med. 24, 1330–1336 (2018).

Kurtovic, L. et al. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure. BMC Med. 17, 45 (2019).

Duffy, P. E. Current approaches to malaria vaccines. Curr. Opin. Microbiol. 70, 102227 (2022).

Richie, T. L. et al. Sporozoite immunization: innovative translational science to support the fight against malaria. Expert Rev. Vaccines 22, 964–1007 (2023).

Moorthy, V., Hamel, M. J. & Smith, P. G. Malaria vaccines for children: and now there are two. Lancet 403, 504–505 (2024).

White, M. T. et al. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect. Dis. 15, 1450–1458 (2015).

Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet 403, 533–544 (2024).

da Veiga, G. T. S., Moriggi, M. R., Vettorazzi, J. F., Muller-Santos, M. & Albrecht, L. Plasmodium vivax vaccine: what is the best way to go? Front. Immunol. 13, 910236 (2022).

... continue reading